Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Both the FDA and the EMA authorize certain insulin products for use in type 2 diabetes (T2D), and some of these indications explicitly allow monotherapy (i.e., insulin alone, without other glucose‑lowering drugs), or at least encompass monotherapy as a clinical option even if the label wording is not limited to “monotherapy‑only.”
…